Pharsight

Drugs that contain Aliskiren Hemifumarate; Amlodipine Besylate

1. Tekamlo patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5559111 NOVARTIS δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides
Jul, 2018

(5 years ago)

US8613949 NOVARTIS Galenical formulations of organic compounds
Dec, 2029

(5 years from now)

Drug Exclusivity Drug Exclusivity Expiration
New Chemical Entity Exclusivity(NCE) Mar 05, 2012
New Combination(NC) Aug 26, 2013

NCE-1 date: 06 March, 2011

Market Authorisation Date: 26 August, 2010

Treatment: Treatment of hypertension

Dosage: TABLET;ORAL

More Information on Dosage

TEKAMLO family patents

Family Patents